Search results
Results from the WOW.Com Content Network
The process starts with a standard salt bath nitrocarburizing cycle, which produces a layer of ε iron nitride. [4] Next, the workpiece is mechanically polished; typical polishing processes include vibratory finishing, lapping, and centerless grinding. Finally, the workpiece is re-immersed into the salt quench bath for 20 to 30 minutes, rinsed ...
Reflect the stage of cancer; By determining the stage of cancer, it's possible to give a prognosis and treatment plan. [4] Screening for cancers; No screening test is wholly specific, and a high level of tumor marker can still be found in benign tumors. The only tumor marker currently used in screening is PSA (prostate-specific antigen ...
A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule." [18] In cancer research and medicine, biomarkers are used in three primary ways: [19] To help diagnose conditions, as in the case of identifying early stage cancers (diagnostic)
Plasma nitriding, also known as ion nitriding, plasma ion nitriding or glow-discharge nitriding, is an industrial surface hardening treatment for metallic materials. In plasma nitriding, the reactivity of the nitriding media is not due to the temperature but to the gas ionized state.
CA 242 is a tumor marker for sialylated Lewis carbohydrates associated with adenocarcinomas and e-selectin-mediated metastatic risk. [1] [2] [3] It is commonly tested along with CEA, CA19-9, and CA242 for detecting pancreatic cancer. [4] The specificity of CA 242 is higher than similar markers.
A panel of epigenetic methylation marker has been explored for prognosis of ovarian cancer, and it is reported that the panel exhibited high specificity and sensitivity (both above 70%) as a screen marker. [5] Epigenetic markers have also shown promising potential as prognostic markers for bladder cancer. [6]
Virtually every cell in the body requires iron in order to function well. Iron is involved in key bodily processes, including the transportation of oxygen in the blood. It also plays a central ...
CD20 is a marker of B cell malignancies. It is found on B-cell lymphomas, hairy cell leukemia, B-cell chronic lymphocytic leukemia, and melanoma cancer stem cells. [14] Immunohistochemistry can be used to determine the presence of CD20 on cells in histological tissue sections.